135 related articles for article (PubMed ID: 1958862)
1. Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: a feasibility study of a novel system.
Curley SA; Byrd DR; Newman RA; Carrasco CH; Cromeens D; Ellis HJ; Chase J; Dougherty T; Wright K; Bodden W
Anticancer Drugs; 1991 Apr; 2(2):175-83. PubMed ID: 1958862
[TBL] [Abstract][Full Text] [Related]
2. Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study.
Curley SA; Newman RA; Dougherty TB; Fuhrman GM; Stone DL; Mikolajek JA; Guercio S; Guercio A; Carrasco CH; Kuo MT
Ann Surg Oncol; 1994 Sep; 1(5):389-99. PubMed ID: 7850540
[TBL] [Abstract][Full Text] [Related]
3. Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration.
Curley SA; Byrd DR; Newman RA; Ellis HJ; Chase J; Carrasco CH; Cleary K; Bodden W; Hohn DC
Surgery; 1993 Sep; 114(3):579-85. PubMed ID: 8367814
[TBL] [Abstract][Full Text] [Related]
4. Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration.
Curley SA; Stone DL; Fuhrman GM; Hohn DC; Siddik ZH; Newman RA
Cancer Chemother Pharmacol; 1993; 33(3):251-7. PubMed ID: 8269607
[TBL] [Abstract][Full Text] [Related]
5. Hepatic artery infusion of doxorubicin with hepatic venous drug extraction.
August DA; Verma N; Andrews JC; Vaerten MA; Brenner DE
J Surg Res; 1994 Jun; 56(6):611-9. PubMed ID: 8015319
[TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial infusion of verapamil and doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration: pharmacological evaluation of reduction in systemic drug exposure and assessment of hepatic toxicity.
Fuhrman GM; Cromeens DM; Newman RA; Cleary KR; Carrasco CH; Wright KC; Guercio S; Guercio A; Curley SA
Surg Oncol; 1994 Feb; 3(1):17-25. PubMed ID: 8186867
[TBL] [Abstract][Full Text] [Related]
7. Safe anesthetic management of patients undergoing a novel method of treating human hepatocellular cancer.
Dougherty TB; Mikolajek JA; Curley SA
J Clin Anesth; 1997 May; 9(3):220-7. PubMed ID: 9172030
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic evaluation of percutaneous hepatic venous isolation for administration of regional chemotherapy.
August DA; Verma N; Vaerten MA; Shah R; Andrews JC; Brenner DE
Surg Oncol; 1995 Aug; 4(4):205-16. PubMed ID: 8528483
[TBL] [Abstract][Full Text] [Related]
9. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors.
Ravikumar TS; Pizzorno G; Bodden W; Marsh J; Strair R; Pollack J; Hendler R; Hanna J; D'Andrea E
J Clin Oncol; 1994 Dec; 12(12):2723-36. PubMed ID: 7989950
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of hepatic doxorubicin extraction with extracorporeal filtration avoids the dose-dependent, nonlinear increase in AUC observed with systemic administration.
Sturgill MG; Brenner DE; August DA
Cancer Chemother Pharmacol; 1998; 41(3):193-200. PubMed ID: 9443635
[TBL] [Abstract][Full Text] [Related]
12. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors.
Ku Y; Fukumoto T; Tominaga M; Iwasaki T; Maeda I; Kusunoki N; Obara H; Sako M; Suzuki Y; Kuroda Y; Saitoh Y
Am J Surg; 1997 Feb; 173(2):103-9. PubMed ID: 9074373
[TBL] [Abstract][Full Text] [Related]
13. Treatment of liver cancers with complete hepatic venous isolation and extracorporeal chemofiltration.
Curley SA
Surgery; 1995 Jun; 117(6):718-9. PubMed ID: 7778038
[No Abstract] [Full Text] [Related]
14. Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy.
Graham RA; Siddik ZH; Hohn DC
Cancer Chemother Pharmacol; 1990; 26(3):210-4. PubMed ID: 2357769
[TBL] [Abstract][Full Text] [Related]
15. Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum.
Hamana S; Motoyama S; Takeuchi S; Ku Y; Yoshida S; Miyahara Y; Tateiwa Y; Maruo T
Am J Clin Oncol; 2001 Jun; 24(3):241-6. PubMed ID: 11404493
[TBL] [Abstract][Full Text] [Related]
16. Novel Extracorporeal Hemoperfusion System for Hepatic Arterial Infusion of Cisplatin.
So S; Komatsu S; Takebe A; Kido M; Tanaka M; Toyama H; Ueno K; Fukumoto T
Anticancer Res; 2018 Nov; 38(11):6445-6452. PubMed ID: 30396970
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary observation on hepatic arterial infusion under temporary hepatic circulation occlusion in rabbits].
Liu X; Xiong L; Xu R; Cao X
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):91-4. PubMed ID: 25975683
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies.
Pingpank JF; Libutti SK; Chang R; Wood BJ; Neeman Z; Kam AW; Figg WD; Zhai S; Beresneva T; Seidel GD; Alexander HR
J Clin Oncol; 2005 May; 23(15):3465-74. PubMed ID: 15908655
[TBL] [Abstract][Full Text] [Related]
19. Effect of sodium thiosulfate on cisplatin removal with complete hepatic venous isolation and extracorporeal charcoal hemoperfusion: a pharmacokinetic evaluation.
Kusunoki N; Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Muramatsu S; Sugimoto T; Tsuchida S; Takamatsu M; Suzuki Y; Kuroda Y
Ann Surg Oncol; 2001 Jun; 8(5):449-57. PubMed ID: 11407521
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion chemotherapy using fluorouracil, epirubicin, and mitomycin C for patients with liver metastases from gastric cancer after treatment failure of systemic S-1 plus cisplatin.
Seki H; Ohi H; Ozaki T; Yabusaki H
Acta Radiol; 2016 Jul; 57(7):781-8. PubMed ID: 26339040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
